Cargando…

The cell surface mucin podocalyxin regulates collective breast tumor budding

BACKGROUND: Overexpression of the transmembrane sialomucin podocalyxin, which is known to play a role in lumen formation during polarized epithelial morphogenesis, is an independent indicator of poor prognosis in a number of epithelial cancers, including those that arise in the breast. Therefore, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Graves, Marcia L., Cipollone, Jane A., Austin, Pamela, Bell, Erin M., Nielsen, Julie S., Gilks, C. Blake, McNagny, Kelly M., Roskelley, Calvin D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722710/
https://www.ncbi.nlm.nih.gov/pubmed/26796961
http://dx.doi.org/10.1186/s13058-015-0670-4
_version_ 1782411401658105856
author Graves, Marcia L.
Cipollone, Jane A.
Austin, Pamela
Bell, Erin M.
Nielsen, Julie S.
Gilks, C. Blake
McNagny, Kelly M.
Roskelley, Calvin D.
author_facet Graves, Marcia L.
Cipollone, Jane A.
Austin, Pamela
Bell, Erin M.
Nielsen, Julie S.
Gilks, C. Blake
McNagny, Kelly M.
Roskelley, Calvin D.
author_sort Graves, Marcia L.
collection PubMed
description BACKGROUND: Overexpression of the transmembrane sialomucin podocalyxin, which is known to play a role in lumen formation during polarized epithelial morphogenesis, is an independent indicator of poor prognosis in a number of epithelial cancers, including those that arise in the breast. Therefore, we set out to determine if podocalyxin plays a functional role in breast tumor progression. METHODS: MCF-7 breast cancer cells, which express little endogenous podocalyxin, were stably transfected with wild type podocalyxin for forced overexpression. 4T1 mammary tumor cells, which express considerable endogenous podocalyxin, were retrovirally transduced with a short hairpin ribonucleic acid (shRNA) targeting podocalyxin for stable knockdown. In vitro, the effects of podocalyxin on collective cellular migration and invasion were assessed in two-dimensional monolayer and three-dimensional basement membrane/collagen gel culture, respectively. In vivo, local invasion was assessed after orthotopic transplantation in immunocompromised mice. RESULTS: Forced overexpression of podocalyxin caused cohesive clusters of epithelial MCF-7 breast tumor cells to bud off from the primary tumor and collectively invade the stroma of the mouse mammary gland in vivo. This budding was not associated with any obvious changes in histoarchitecture, matrix deposition or proliferation in the primary tumour. In vitro, podocalyxin overexpression induced a collective migration of MCF-7 tumor cells in two-dimensional (2-D) monolayer culture that was dependent on the activity of the actin scaffolding protein ezrin, a cytoplasmic binding partner of podocalyxin. In three-dimensional (3-D) culture, podocalyxin overexpression induced a collective budding and invasion that was dependent on actomyosin contractility. Interestingly, the collectively invasive cell aggregates often contained expanded microlumens that were also observed in vivo. Conversely, when endogenous podocalyxin was removed from highly metastatic, but cohesive, 4T1 mammary tumor cells there was a decrease in collective invasion in three-dimensional culture. CONCLUSIONS: Podocalyxin is a tumor cell-intrinsic regulator of experimental collective tumor cell invasion and tumor budding. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13058-015-0670-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4722710
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47227102016-01-23 The cell surface mucin podocalyxin regulates collective breast tumor budding Graves, Marcia L. Cipollone, Jane A. Austin, Pamela Bell, Erin M. Nielsen, Julie S. Gilks, C. Blake McNagny, Kelly M. Roskelley, Calvin D. Breast Cancer Res Research Article BACKGROUND: Overexpression of the transmembrane sialomucin podocalyxin, which is known to play a role in lumen formation during polarized epithelial morphogenesis, is an independent indicator of poor prognosis in a number of epithelial cancers, including those that arise in the breast. Therefore, we set out to determine if podocalyxin plays a functional role in breast tumor progression. METHODS: MCF-7 breast cancer cells, which express little endogenous podocalyxin, were stably transfected with wild type podocalyxin for forced overexpression. 4T1 mammary tumor cells, which express considerable endogenous podocalyxin, were retrovirally transduced with a short hairpin ribonucleic acid (shRNA) targeting podocalyxin for stable knockdown. In vitro, the effects of podocalyxin on collective cellular migration and invasion were assessed in two-dimensional monolayer and three-dimensional basement membrane/collagen gel culture, respectively. In vivo, local invasion was assessed after orthotopic transplantation in immunocompromised mice. RESULTS: Forced overexpression of podocalyxin caused cohesive clusters of epithelial MCF-7 breast tumor cells to bud off from the primary tumor and collectively invade the stroma of the mouse mammary gland in vivo. This budding was not associated with any obvious changes in histoarchitecture, matrix deposition or proliferation in the primary tumour. In vitro, podocalyxin overexpression induced a collective migration of MCF-7 tumor cells in two-dimensional (2-D) monolayer culture that was dependent on the activity of the actin scaffolding protein ezrin, a cytoplasmic binding partner of podocalyxin. In three-dimensional (3-D) culture, podocalyxin overexpression induced a collective budding and invasion that was dependent on actomyosin contractility. Interestingly, the collectively invasive cell aggregates often contained expanded microlumens that were also observed in vivo. Conversely, when endogenous podocalyxin was removed from highly metastatic, but cohesive, 4T1 mammary tumor cells there was a decrease in collective invasion in three-dimensional culture. CONCLUSIONS: Podocalyxin is a tumor cell-intrinsic regulator of experimental collective tumor cell invasion and tumor budding. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13058-015-0670-4) contains supplementary material, which is available to authorized users. BioMed Central 2016-01-22 2016 /pmc/articles/PMC4722710/ /pubmed/26796961 http://dx.doi.org/10.1186/s13058-015-0670-4 Text en © Graves et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Graves, Marcia L.
Cipollone, Jane A.
Austin, Pamela
Bell, Erin M.
Nielsen, Julie S.
Gilks, C. Blake
McNagny, Kelly M.
Roskelley, Calvin D.
The cell surface mucin podocalyxin regulates collective breast tumor budding
title The cell surface mucin podocalyxin regulates collective breast tumor budding
title_full The cell surface mucin podocalyxin regulates collective breast tumor budding
title_fullStr The cell surface mucin podocalyxin regulates collective breast tumor budding
title_full_unstemmed The cell surface mucin podocalyxin regulates collective breast tumor budding
title_short The cell surface mucin podocalyxin regulates collective breast tumor budding
title_sort cell surface mucin podocalyxin regulates collective breast tumor budding
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722710/
https://www.ncbi.nlm.nih.gov/pubmed/26796961
http://dx.doi.org/10.1186/s13058-015-0670-4
work_keys_str_mv AT gravesmarcial thecellsurfacemucinpodocalyxinregulatescollectivebreasttumorbudding
AT cipollonejanea thecellsurfacemucinpodocalyxinregulatescollectivebreasttumorbudding
AT austinpamela thecellsurfacemucinpodocalyxinregulatescollectivebreasttumorbudding
AT bellerinm thecellsurfacemucinpodocalyxinregulatescollectivebreasttumorbudding
AT nielsenjulies thecellsurfacemucinpodocalyxinregulatescollectivebreasttumorbudding
AT gilkscblake thecellsurfacemucinpodocalyxinregulatescollectivebreasttumorbudding
AT mcnagnykellym thecellsurfacemucinpodocalyxinregulatescollectivebreasttumorbudding
AT roskelleycalvind thecellsurfacemucinpodocalyxinregulatescollectivebreasttumorbudding
AT gravesmarcial cellsurfacemucinpodocalyxinregulatescollectivebreasttumorbudding
AT cipollonejanea cellsurfacemucinpodocalyxinregulatescollectivebreasttumorbudding
AT austinpamela cellsurfacemucinpodocalyxinregulatescollectivebreasttumorbudding
AT bellerinm cellsurfacemucinpodocalyxinregulatescollectivebreasttumorbudding
AT nielsenjulies cellsurfacemucinpodocalyxinregulatescollectivebreasttumorbudding
AT gilkscblake cellsurfacemucinpodocalyxinregulatescollectivebreasttumorbudding
AT mcnagnykellym cellsurfacemucinpodocalyxinregulatescollectivebreasttumorbudding
AT roskelleycalvind cellsurfacemucinpodocalyxinregulatescollectivebreasttumorbudding